HomeProductsBioactive CompoundsGPCR & G Protein TargetsAdenosine ReceptorTozadenant
Chemical structure of CAS 870070-55-6

Tozadenant

CAS No.870070-55-6
MDL No.MFCD21642026
MFC19H26N4O4S
MW406.50
InChI KeyXNBRWUQWSKXMPW-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Tozadenant is a benzothiazole compound.

CAS No.870070-55-6
Product NameTozadenant

Biological Targets

ADORA2A

Associated Conditions

liver disease·Parkinson disease·cocaine dependence
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.

The Lancet. Neurology • Vol. 13, Issue 8 • 2014
PMID: 25008546DOI: 10.1016/S1474-4422(14)70148-6

Adenosine A2A receptor as a drug discovery target.

Journal of medicinal chemistry • Vol. 57, Issue 9 • 2014
PMID: 24164628DOI: 10.1021/jm4011669

Documentation